Kopp M - Search Results

1

Rapid Next-Generation Sequencing-Based Diagnostics of Bacteremia in Septic Patients.

Grumaz C, Hoffmann A, Vainshtein Y, Kopp M, Grumaz S, Stevens P, Decker SO, Weigand MA, Hofer S, Brenner T, Sohn K. Grumaz C, et al. Among authors: kopp m. J Mol Diagn. 2020 Mar;22(3):405-418. doi: 10.1016/j.jmoldx.2019.12.006. J Mol Diagn. 2020. PMID: 32146977 Free article.

2

Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.

Harter J, Buth E, Johaenning J, Battke F, Kopp M, Zelba H, Schulze M, Koedding J, Biskup S. Harter J, et al. Among authors: kopp m. J Mol Diagn. 2024 Jan;26(1):61-72. doi: 10.1016/j.jmoldx.2023.10.001. Epub 2023 Oct 20. J Mol Diagn. 2024. PMID: 37865292 Free article.

3

Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study.

Forschner A, Weißgraeber S, Hadaschik D, Schulze M, Kopp M, Kelkenberg S, Sinnberg T, Garbe C, Biskup S, Battke F. Forschner A, et al. Among authors: kopp m. Onco Targets Ther. 2020 Jun 4;13:5017-5032. doi: 10.2147/OTT.S248237. eCollection 2020. Onco Targets Ther. 2020. PMID: 32581559 Free PMC article.

4

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.

Blumendeller C, Boehme J, Frick M, Schulze M, Rinckleb A, Kyzirakos C, Kayser S, Kopp M, Kelkenberg S, Pieper N, Bartsch O, Hadaschick D, Battke F, Stenzl A, Biskup S. Blumendeller C, et al. Among authors: kopp m. J Immunother Cancer. 2021 Jan;9(1):e001406. doi: 10.1136/jitc-2020-001406. J Immunother Cancer. 2021. PMID: 33431630 Free PMC article.

5

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study.

Forschner A, Battke F, Hadaschik D, Schulze M, Weißgraeber S, Han CT, Kopp M, Frick M, Klumpp B, Tietze N, Amaral T, Martus P, Sinnberg T, Eigentler T, Keim U, Garbe C, Döcker D, Biskup S. Forschner A, et al. Among authors: kopp m. J Immunother Cancer. 2019 Jul 12;7(1):180. doi: 10.1186/s40425-019-0659-0. J Immunother Cancer. 2019. PMID: 31300034 Free PMC article. Clinical Trial.

6

Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions.

Burtscher J, Strasser B, Pepe G, Burtscher M, Kopp M, Di Pardo A, Maglione V, Khamoui AV. Burtscher J, et al. Among authors: kopp m. Int J Mol Sci. 2024 Apr 25;25(9):4696. doi: 10.3390/ijms25094696. Int J Mol Sci. 2024. PMID: 38731912 Free PMC article. Review.

7

Development of a Trusted Third Party at a Large University Hospital: Design and Implementation Study.

Wündisch E, Hufnagl P, Brunecker P, Meier Zu Ummeln S, Träger S, Kopp M, Prasser F, Weber J. Wündisch E, et al. Among authors: kopp m. JMIR Med Inform. 2024 Apr 18;12:e53075. doi: 10.2196/53075. JMIR Med Inform. 2024. PMID: 38632712 Free PMC article.

8

Experimental evidence for Parthanatos-like mode of cell death of heat-damaged human skin fibroblasts in a cell culture-based in vitro burn model.

Schiefer JL, Wergen NM, Grieb G, Bagheri M, Seyhan H, Badra M, Kopp M, Fuchs PC, Windolf J, Suschek CV. Schiefer JL, et al. Among authors: kopp m. Burns. 2024 Mar 16:S0305-4179(24)00086-X. doi: 10.1016/j.burns.2024.03.014. Online ahead of print. Burns. 2024. PMID: 38570249 Free article.

9

Diagnostic Challenges and Imaging Considerations for Intraparotid Facial Nerve Schwannoma: A Case Report and Literature Review.

Luzha J, Kopp M, Wiesmüller M, Taha L, Rupp R, Mantsopoulos K, Koch M, Iro H, Sievert M. Luzha J, et al. Among authors: kopp m. Am J Case Rep. 2024 Mar 29;25:e942870. doi: 10.12659/AJCR.942870. Am J Case Rep. 2024. PMID: 38549237 Free PMC article. Review.

10

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.

Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

729 results

Search Page